Mauna Kea Technologies is a global medical device company focused on eliminating uncertainties related to the diagnosis and treatment of cancer and other diseases thanks to real time in vivo microscopic visualization with Confocal Laser Endomicroscopy. The Company’s flagship product, Cellvizio, is used routinely in gastroenterology today and has received clearance to sell in a wide range of applications in more than 40 countries, including the United States, Europe, Japan, China, Canada, Brazil and Mexico. Mission: To eliminate diagnostic and treatment uncertainties
51 to 200
TypeCompany - Private
Revenue$10 to $25 million (USD)
IndustryHealth Care Services & Hospitals
CompetitorsUnknown
Founded2000